XML 33 R22.htm IDEA: XBRL DOCUMENT v3.20.2

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2020

Stockholders' Equity Note [Abstract]

Schedule of changes in options outstanding

		Number of Options				Weighted Average Exercise Price For Share				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Outstanding and expected to vest at December 31, 2019			3,615,602			$	19.96				9.2			$	74,837,043
Granted			950,000			$	39.82				9.54			$	2,256,000
Exercised			(239,865	)		$	3.98				-			$	-
Forfeited			(215,312	)		$	21.57				-			$	-
Outstanding  at September 30, 2020			4,110,425			$	25.40				8.72			$	61,858,297
Options exercisable at September 30, 2020			982,608			$	13.87				7.77			$	24,526,894

Schedule of changes in outstanding warrants

		Number of Shares				Weighted Average Exercise Price Per Share
Outstanding and vested at December 31, 2019			3,646,872			$	6.83
Granted			122,000				31.69
Exercised			(1,081,581	)			7.34
Forfeited			(13,026	)			16.00
Outstanding  at September 30, 2020			2,674,265			$	7.77
Warrants exercisable at September 30, 2020			2,646,141			$	7.81

Schedule of stock-based compensation expense

		Nine Months Ended September 30, 2020				Nine Months Ended September 30, 2019
Research and development		$	4,635,300			$	259,400
General and administrative			12,951,200				1,296,500
Total		$	17,586,500			$	1,555,900

X

- Definition

Schedule of share based compensation expense includes stock options warrants and restricted stock .

+ References

No definition available.

+ Details

Name:	rlmd_ScheduleOfShareBasedCompensationExpenseIncludesStockOptionsWarrantsAndRestrictedStockTableTextBlock
Namespace Prefix:	rlmd_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share warrants (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share warrants or share units that were granted, exercised or converted, forfeited, and expired during the year.

+ References

No definition available.

+ Details

Name:	rlmd_ScheduleOfShareBasedCompensationWarrantsActivityTableTextBlock
Namespace Prefix:	rlmd_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration